Subsidies
Subsidies
subsidy
| Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
|---|---|---|---|---|---|---|---|
| development of a test for non-invasive early diagnosis of lung cancer based on molecular markers, imaging and Big Data-oncoLung Dx tools. | CPP2021-008336 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI Projects at partnership Public-Private | 23-12-2022 | 174.754,00€ | MRR Funds |
| Nanovectors for direct, loco-regional and controlled intravenous administration of antitumor drugs. Strategies to minimize adverse effects and maximize therapeutic response. maximize therapeutic response. ONCOLIBERYX | CPP2021-008362 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI Projects at partnership Public-Private | 23-12-2022 | 423.957,00€ | MRR Funds |
| Novel feed nanosupplement for pregnant and lactating sows (SOWCAPS) | CPP2021-008769 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI Projects at partnership Public-Private | 23-12-2022 | 78.140,08€ | MRR Funds |
| DIGITAL TWIN FOR THE NEW GENERATION OF INTELLIGENT BUILDINGS (DigiTwin) | CPP2021-008909 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI Projects at partnership Public-Private | 23-12-2022 | 248.967,75€ | MRR Funds |
| Covid Content Curation | GN2022/49 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | University of Navarra | 2022 GN Projects of research in health | 22-12-2022 | 49.450,00€ | - |
| Single-cell multiomics for for ultra-sensitive and minimally invasive assessment of treatment efficacy in Waldenström¿s Macroglobulinemia. | PI22/00865 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 22-12-2022 | 171.820,00€ | ERDF funds |
| HE-UHR-RM M7 COLLIMATOR Equipment | IFEQ22/00167 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Equipment | 22-12-2022 | 79.000,00€ | MRR Funds |
| Validation of epigenetic biomarkers associated with major depression and resistance to antidepressant treatment. | GN2022/57 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 22-12-2022 | 79.998,87€ | - |
| Reversal of immunotherapy resistance in lung cancer due to absence of the tumor suppressor gene PTEN | GN2022/50 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 22-12-2022 | 76.934,16€ | - |
| Validation of Structures of therapeutic RNA for clinical use. | PDC2022-133961-I00 | MINISTRY OF SCIENCE AND INNOVATION | FIMA 2022 MCI - AEI RESEARCH AND DEVELOPMENT+I PROJECTS FOR PROOF-OF-CONCEPT TESTING | 21-12-2022 | 149.500,00€ | - | |
| Probiotics as immunomodulatory agents for vaccines | GN2022/04 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 20-12-2022 | 79.119,13€ | - |
| Early treatment strategies of osteomyelitis in the prevention of fracture pseudarthrosis. | GN2022/06 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 20-12-2022 | 48.875,00€ | - |
| RodríguezOroz_GN2022/28_Restoration of synaptic function in the premotor state of Parkinson's disease by protein modulation with gene therapy and molecular therapies. | GN2022/28 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 16-12-2022 | 79.349,14€ | - |
| essay Phase I/II clinical trial for the treatment of graft-versus-host disease with a new generation of mesenchymal stromal cells ectopically expressing CXCR4 and IL10 | ICI22/00067 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.207.250,00€ | - |
| Decross-priming dendritic cells as vaccines in an immunotherapy strategy for renal and urothelial cancers. | ICI22/00115 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.007.600,00€ | MRR Funds |
| Patient Dignity Question as an intervention for the alleviation of suffering: A mixed-method study in patients with advanced disease. | PI22/01504 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 15-12-2022 | 10.890,00€ | ERDF funds |
| Diagnostic platform of high performing for personalized medicine in patients with acute myeloblastic leukemia. | PMP22/00069 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2022 AES Personalized Medicine | 15-12-2022 | 126.252,67€ | - |
| Linking phenotype and molecular genotype to prognosis in Primary Systemic Amyloidosis: A European registry and network of samples to optimize diagnosis and management of Primary Systemic Amyloidosis. | AC22/00057 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES International Joint Programming Projects | 15-12-2022 | 174.845,00€ | MRR Funds |
| Personalising the clinical decision making in ovarian cancer through patient-derived in vitro models. | HIGH SCHOOL CARLOS III HEALTH CENTRE | FIMA 2022 AES International partnership Projects | 15-12-2022 | 159.175,50€ | - | ||
| Longitudinal analysis of the determinants of intimate partner violence in Spanish adolescents. Follow-up of project Yourlife | PI22/00624 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 15-12-2022 | 26.620,00€ | ERDF funds |
| Involvement of adipo-myokines in the development of sarcopenic obesity and associated comorbidities. | PI22/00223 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 123.420,00€ | ERDF funds |
| Ullate, Asier - Prósper Felipe - CD22/00027 | CD22/00027 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Sara Borrell | 14-12-2022 | 95.000,00€ | - |
| New strategies for the treatment of microcytic lung cancer based on the elimination of the immunosuppressive microenvironment due to tumor cell intrinsic factors | PI22/01253 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 244.420,00€ | - |
| Characterization of vascular oxidative stress in the pathophysiology of diabetes: NADPH oxidase 5 as a potential therapeutic target. | PI22/01450 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 183.920,00€ | ERDF funds |
| Expanded LifeBreast trial: long-term lifestyle changes may improve the prognosis of breast cancer | PI22/00828 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 136.004,00€ | - |
| Changes in adipose tissue inflammation associated with obesity and its comorbidities after bariatric surgery induced by the follistatin-like protein 1 (FSTL1) | PI22/00745 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 232.320,00€ | ERDF funds |
| Non-invasive diagnosis of cancer patients using artificial intelligence applied to the analysis of circulating tumor cells in blood (DeepCTC). | TED2021-131300B-I00 | MINISTRY OF SCIENCE AND INNOVATION | FIMA 2021 MCIU ECOLOGICAL AND DIGITAL TRANSITION | 01-12-2022 | 187.450,00€ | MRR Funds | |
| GNI INVESTIGO 2022 C. ORTIZ DE SOLORZANO | 0011-4001-2022-000081 | GOVERNMENT OF NAVARRA | FIMA 2021 GN Investigo | 01-12-2022 | 33.108,92€ | ERDF funds | |
| Evaluating the therapeutic potential of immunosuppressive paracrine cytokines in the tumor microenvironment of metastatic lesions. | SPANISH ASSOCIATION AGAINST CANCER | TRANSCAN-3 JTC 2022 | 01-12-2022 | 150.000,00€ | - | ||
| Development of advanced medicinal products to express IL15 variants for optimizing cancer immunotherapy. | FPU21/00042 | MINISTRY OF SCIENCE AND INNOVATION | FIMA 2021 - MINECO FPU GRANTS | 30-11-2022 | 73.144,97€ | ERDF funds | |
